Blaustein Marc 4
4 · Finch Therapeutics Group, Inc. · Filed Sep 10, 2021
Insider Transaction Report
Form 4
Blaustein Marc
Chief Operating Officer
Transactions
- Award
Employee Stock Option (right to buy)
2021-09-08+150,000→ 150,000 totalExercise: $15.56Exp: 2031-09-07→ Common Stock (150,000 underlying)
Footnotes (1)
- [F1]Twenty-five percent (25%) of the shares subject to the option vest on September 8, 2022, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.